Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 09-2018 | 09-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 38,627 | 7,850 | 461 | 400 |
| Marketable Securities | 0 | 200 | N/A | N/A |
| Receivables | 27,540 | 6,427 | N/A | N/A |
| Inventories | 51,486 | 9,404 | N/A | N/A |
| Other current assets | 0 | 38 | 0 | 0 |
| TOTAL | $119,701 | $26,614 | $461 | $400 |
| Non-Current Assets | ||||
| PPE Net | 42,233 | 13,968 | N/A | N/A |
| Investments And Advances | 189 | 81 | N/A | N/A |
| Other Non-Current Assets | 6,707 | 2,066 | 0 | 0 |
| TOTAL | $49,129 | $16,115 | $0 | $0 |
| Total Assets | $168,830 | $42,729 | $461 | $400 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 1,459 | 6,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 19,057 | 7,992 | 4 | 0 |
| Accrued Expenses | 1,793 | 277 | 30 | 0 |
| TOTAL | $28,846 | $14,886 | $34 | $0 |
| Non-Current Liabilities | ||||
| Long Term Debt | 8,116 | N/A | N/A | N/A |
| Deferred Revenues | N/A | 50 | N/A | N/A |
| Other Non-Current Liabilities | 320 | -194 | 0 | 0 |
| TOTAL | $8,757 | $0 | $0 | $0 |
| Total Liabilities | $37,603 | $14,886 | $34 | $0 |
| Shareholders' Equity | ||||
| Common Shares | 122,807 | 34,065 | 556 | 400 |
| Retained earnings | -8,189 | -9,834 | -211 | 0 |
| Other shareholders' equity | 16,929 | 3,418 | 82 | 0 |
| TOTAL | $131,547 | $27,649 | $427 | $400 |
| Total Liabilities And Equity | $169,150 | $42,535 | $461 | $400 |